FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3201509779> ?p ?o ?g. }

• W3201509779 endingPage "4625" @default.
• W3201509779 startingPage "4625" @default.
• W3201509779 abstract "The role of the proangiogenic factor olfactomedin-like 3 (OLFML3) in cancer is unclear. To characterize OLFML3 expression in human cancer and its role during tumor development, we undertook tissue expression studies, gene expression analyses of patient tumor samples, in vivo studies in mouse cancer models, and in vitro coculture experiments. OLFML3 was expressed at high levels, mainly in blood vessels, in multiple human cancers. We focused on colorectal cancer (CRC), as elevated expression of OLFML3 mRNA correlated with shorter relapse-free survival, higher tumor grade, and angiogenic microsatellite stable consensus molecular subtype 4 (CMS4). Treatment of multiple in vivo tumor models with OLFML3-blocking antibodies and deletion of the Olfml3 gene from mice decreased lymphangiogenesis, pericyte coverage, and tumor growth. Antibody-mediated blockade of OLFML3 and deletion of host Olfml3 decreased the recruitment of tumor-promoting tumor-associated macrophages and increased infiltration of the tumor microenvironment by NKT cells. Importantly, targeting OLFML3 increased the antitumor efficacy of anti-PD-1 checkpoint inhibitor therapy. Taken together, the results demonstrate that OLFML3 is a promising candidate therapeutic target for CRC." @default.
• W3201509779 created "2021-09-27" @default.
• W3201509779 creator A5001253381 @default.
• W3201509779 creator A5003192724 @default.
• W3201509779 creator A5007824824 @default.
• W3201509779 creator A5028644220 @default.
• W3201509779 creator A5031185097 @default.
• W3201509779 creator A5036063755 @default.
• W3201509779 creator A5041326746 @default.
• W3201509779 creator A5048762376 @default.
• W3201509779 creator A5062646685 @default.
• W3201509779 creator A5067073528 @default.
• W3201509779 creator A5068821173 @default.
• W3201509779 creator A5078722669 @default.
• W3201509779 creator A5089085923 @default.
• W3201509779 creator A5090614409 @default.
• W3201509779 date "2021-09-15" @default.
• W3201509779 modified "2023-10-13" @default.
• W3201509779 title "Targeting OLFML3 in Colorectal Cancer Suppresses Tumor Growth and Angiogenesis, and Increases the Efficacy of Anti-PD1 Based Immunotherapy" @default.
• W3201509779 cites W1534160952 @default.
• W3201509779 cites W1539571840 @default.
• W3201509779 cites W1578464769 @default.
• W3201509779 cites W1934094702 @default.
• W3201509779 cites W1971620413 @default.
• W3201509779 cites W1973418567 @default.
• W3201509779 cites W1982620568 @default.
• W3201509779 cites W1983517349 @default.
• W3201509779 cites W1984011890 @default.
• W3201509779 cites W1990173431 @default.
• W3201509779 cites W1995037165 @default.
• W3201509779 cites W2009268313 @default.
• W3201509779 cites W2017322644 @default.
• W3201509779 cites W2028825060 @default.
• W3201509779 cites W2034269086 @default.
• W3201509779 cites W2048745419 @default.
• W3201509779 cites W2051268134 @default.
• W3201509779 cites W2052375870 @default.
• W3201509779 cites W2053026927 @default.
• W3201509779 cites W2058797249 @default.
• W3201509779 cites W2059341775 @default.
• W3201509779 cites W2071456955 @default.
• W3201509779 cites W2072042546 @default.
• W3201509779 cites W2076743146 @default.
• W3201509779 cites W2077509510 @default.
• W3201509779 cites W2083802683 @default.
• W3201509779 cites W2092932220 @default.
• W3201509779 cites W2094935740 @default.
• W3201509779 cites W2105453522 @default.
• W3201509779 cites W2106067112 @default.
• W3201509779 cites W2107325549 @default.
• W3201509779 cites W2115515762 @default.
• W3201509779 cites W2121820529 @default.
• W3201509779 cites W2123559545 @default.
• W3201509779 cites W2131783235 @default.
• W3201509779 cites W2135362692 @default.
• W3201509779 cites W2155214429 @default.
• W3201509779 cites W2156006656 @default.
• W3201509779 cites W2157792708 @default.
• W3201509779 cites W2165301909 @default.
• W3201509779 cites W2322919275 @default.
• W3201509779 cites W2472544661 @default.
• W3201509779 cites W2511951051 @default.
• W3201509779 cites W2529375437 @default.
• W3201509779 cites W2533236332 @default.
• W3201509779 cites W2553634649 @default.
• W3201509779 cites W2553755210 @default.
• W3201509779 cites W2591550189 @default.
• W3201509779 cites W2606765235 @default.
• W3201509779 cites W2765947514 @default.
• W3201509779 cites W2766626435 @default.
• W3201509779 cites W2780643755 @default.
• W3201509779 cites W2793490494 @default.
• W3201509779 cites W2800353792 @default.
• W3201509779 cites W2800499107 @default.
• W3201509779 cites W2802731336 @default.
• W3201509779 cites W2883766905 @default.
• W3201509779 cites W2945949187 @default.
• W3201509779 cites W2953676858 @default.
• W3201509779 cites W3084409519 @default.
• W3201509779 cites W3090214243 @default.
• W3201509779 cites W3156165614 @default.
• W3201509779 doi "https://doi.org/10.3390/cancers13184625" @default.
• W3201509779 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8464773" @default.
• W3201509779 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34572851" @default.
• W3201509779 hasPublicationYear "2021" @default.
• W3201509779 type Work @default.
• W3201509779 sameAs 3201509779 @default.
• W3201509779 citedByCount "8" @default.
• W3201509779 countsByYear W32015097792021 @default.
• W3201509779 countsByYear W32015097792022 @default.
• W3201509779 countsByYear W32015097792023 @default.
• W3201509779 crossrefType "journal-article" @default.
• W3201509779 hasAuthorship W3201509779A5001253381 @default.
• W3201509779 hasAuthorship W3201509779A5003192724 @default.
• W3201509779 hasAuthorship W3201509779A5007824824 @default.
• W3201509779 hasAuthorship W3201509779A5028644220 @default.
• W3201509779 hasAuthorship W3201509779A5031185097 @default.
• W3201509779 hasAuthorship W3201509779A5036063755 @default.

• next